Lv11
28 积分 2025-05-26 加入
Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction
4小时前
已完结
De‐novo Design of Structure‐tunable Multivalent Chimeras for Tumor‐Targeted PD‐L1 Degradation and Potentiated Cancer Immunotherapy
26天前
已完结
Combining PD-L1 inhibitors with immunogenic cell death triggered by chemo-photothermal therapy via a thermosensitive liposome system to stimulate tumor-specific immunological response
26天前
已完结
Synergy of Immunostimulatory Genetherapy with Immune Checkpoint Blockade Motivates Immune Response to Eliminate Cancer
27天前
已完结
Flavonoid derivative DMXAA attenuates cisplatin-induced acute kidney injury independent of STING signaling
29天前
已完结
Antivascular therapy of cancer: DMXAA
1个月前
已完结
An overview on Vadimezan (DMXAA): The vascular disrupting agent
1个月前
已完结
Activating CD8+ T Cells by Pt(IV) Prodrug‐Based Nanomedicine and aPD‐L1 Antibody for Enhanced Cancer Immunotherapy
1个月前
已完结
Discovery of Naphthyridinone Derivatives as Selective and Potent PKMYT1 Inhibitors with Antitumor Efficacy
1个月前
已完结
Discovery of Novel Pyrimidine-4,6-diamine-Based OLIG2 Inhibitors as Potent Anti-Glioblastoma Agents
1个月前
已完结
皖公网安备34019202002308
